Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier-Kohler, Carmen Prof. Dr. (1) Chen, Wei Prof. Dr. (1) Chu, Van Trung Dr. (1) Daniel, Peter Prof. Dr. (2) Di Virgilio, Michela Prof. Dr. (1) Graf, Robin Dr. (1) Hübner, Norbert Prof. Dr. (1) Janz, Martin Dr. (6) Kammertöns, Thomas Dr. (1) Kempa, Stefan Dr. (1) Kirchner, Marieluise Dr. (1) Kopp, Joachim Dr. (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (3) Lewin, Gary Prof. Dr. (1) Mastrobuoni, Guido Dr. (1) Mathas, Stephan Dr. (9) Obermayer-Wasserscheid, Benedikt Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (12) Siffrin, Volker (1) Sommer, Christian (1) Uckert, Wolfgang Prof. Dr. (3) Wanker, Erich Prof. Dr. (1) Wollert-Wulf, Brigitte (3) Wyler, Emanuel Dr. (1) Zauber, Henrik Dr. (3) Zinzen, Robert Patrick Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (4) (-) Lusatis, Simone (1) (-) Biologie maligner Lymphome (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (4) Systembiologie von Gen-regulatorischen Elementen (1) 1992 (4) 1993 (7) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (2) 2009 (2) 2010 (7) 2012 (6) 2013 (11) 2014 (4) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (6) 2022 (6) 2023 (6) 2024 (2) 5 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Lusatis, SimoneBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 20062015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein